Although there is a limited number of clinical studies regarding PDK/PDC axis in MS patients, Nijland and colleagues’ demonstrated increased expression of axonal PDC in demyelinated lesions of MS patients and suggested that glucose metabolism is increased in axonal lesions (43). Here, PDC is linked to myeloid sarcoma.